Retroviruses and the Pathogenesis of Systemic Sclerosis

References

• Schattner A., Rager-Zisman B. Virus-induced autoimmunity. Rev. Infect. Dis. 1990; 12: 204–222
   PubMedGoogle Scholar
• Krieg A. M., Gourley M. F., Perl A. Endogenous retroviruses: Potential etiologic agents in auto-immunity. FASEB J. 1992; 6: 2537–2544
   PubMed Web of Science ®Google Scholar
• Kalden J. R., Herrmann M. Autoimmune diseases in humans, e.g. autoimmune rheumatic diseases. Intervirol. 1993; 35: 176–185
   PubMedGoogle Scholar
• Abraham G. N., Khan A. S. Human endogenous retroviruses and immune diseases. Clin. Immunol. Immunopathol. 1990; 56: 1–8
   Google Scholar
• McCabe E. R. B., Kersey J. H., Vandersteen P. J., Vosika G. J. Reverse transcriptase in a patient with seleroderma. Biochem. Med. 1979; 21: 47–54
   PubMedGoogle Scholar
• Cullen B. R. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 1992; 56: 375–394
   PubMedGoogle Scholar
• Onions D. Integration of viruses into chromosomal DNA. J. Pathol. 1991; 163: 191–197
   Google Scholar
• Leib-Mösch C., Bachmann M., Brack-Werner R., Erfle V., Hehlmann R. Expression and biological significance of human endogenous retroviral sequences. Leukemia 1992; 6: 72s–75s
   Google Scholar
• Samuelson L. C., Wiebauer K., Snow C. M., Meisler M. H. Retroviral and pseudogene insertion sites reveal the lineage of human salivary and pancreatic amylase genes from a single gene during primate evolution. Mol Cell Biol. 1990; 10: 2513–2520
   PubMedGoogle Scholar
• Kazazian H. H., Wong C., Youssoufian H., Scott A. R., Philips D. G., Antonarakis S. E. Haemophilia A resulting from de novo insertion of LI sequences represents a novel mechanism for mutation in man. Nature 1988; 332: 164–166
   PubMed Web of Science ®Google Scholar
• Mountz J. D., Talal N. Retroviruses, apoptosis and autogenes. Immunol. Today 1993; 14: 532–536
   PubMedGoogle Scholar
• Dang H., Dauphinee M. J., Talal N., Garry R. F., Seibold J. R., Medsger T. A., Alexander S. Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum. 1991; 34: 1336–1337
   PubMed Web of Science ®Google Scholar
• Jehuda-Cohen T., Slade B. A., Powel J. ü., Villinger F., Barun D., Folks T. M., McClurc H. M., Sell K. W., Ahmed-Ansari A. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type I (HIV-1) in HIV-1 seronegative individuals. Proc. Nail. Acad. Sci. USA 1990; 87: 3972–3976
   PubMed Web of Science ®Google Scholar
• Banki K., Maceda J., Hurley E., Ablonzy E., Mattson D. H., Szegedy L., Hung C. Human T-cell lymphotropic virus (HTl.V)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-1 gag-reactive auloantibodies. Proc. Natl. Acad. Sci. USA 1992; 89: 1939–1943
   PubMed Web of Science ®Google Scholar
• Rittner G., Schwanitz G., Baur M. P., Black C. M., Welsh K. I., Kuhnl P., Rittner C. Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes. Hum. Genet. 1988; 81: 64–70
   Google Scholar
• Query C. C., Keene J. D. A human autoimmune protein associated with Ul RNA contains a region of homology that is cross-reaclive with retroviral p30gag antigen. Cell 1987; 51: 211–220
   PubMed Web of Science ®Google Scholar
• Guldner H. H., Szostecki C., Vosberg H. P., Lakomek H. J., Penner E., Bautz F. A. Scl-70 autoanti-bodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase 1. Chromosoma 1986; 94: 132–138
   PubMed Web of Science ®Google Scholar
• Maul G. G., French B. T., Venrooij W. J., Jimenez S. A. Topoisomerase 1 identified by scleroderma 70 antisera: Enrichment of topoisomerase 1 at the centromere in mouse mitotic cells before anaphase. Proc. Natl. Acad. Sci. USA 1986; 83: 5145–5149
   PubMed Web of Science ®Google Scholar
• Shero J. H., Bordwell B., Rothield N. F., Earnshaw W. C. High tilers of autoantibodies to topoisomerase 1 (Scl-70) in sera from scleroderma patients. Science 1986; 231: 737–740
   PubMed Web of Science ®Google Scholar
• Maul G. G., Jimenez S. A., Riggs E., Ziemnicka-Kotula D. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase 1989; 1, Sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc. Nail. Acad. Sci. USA; 86:8492–8496
   Google Scholar
• D'Arpa P., White-Cooper H., Cleveland D. W., Rothfield N. F., Eamshaw W. C. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase 1 (Scl-70) recognized by sera of scleroderma patients. Arthritis Rheum. 1990; 33: 1501–1511
   PubMedGoogle Scholar
• Verheijen R., Hoogen F. V. D., Bcijer R., Ritcher A., Penner E., Habets W. J. A recombinant topoisomerase 1 used for autoantibody detection in sera from patients with systemic sclerosis. Clin. Exp. Immunol. 1990; 80: 38–43
   PubMed Web of Science ®Google Scholar
• Kuwana M., Kaburaki J., Mimori T., Tojo T., Homma M. Autoantigenic epitopes of DNA to-poisomerase I. Clinical and immunogenic associations in systemic sclerosis. Arthritis Rheum. 1993; 36: 1406–1413
   Google Scholar
• Douvas A., Sobelman S. Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses. Proc. Natl. Acad. Sci. USA 1991; 88: 6328–6332
   PubMed Web of Science ®Google Scholar
• Weis J. H., Faras A. J. DNA topoisomerase activity associated with Rous sarcoma virus. Virology 1981; 114: 563–566
   Google Scholar
• Pnel E., Showalter S. D., Roberts M., Oroszlan S., Segal S., Aboud M., Blair D. G. Topoisomerase 1 activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. F. MBO J. 1990; 9: 4167–4172
   Google Scholar
• Yoshimura M., Jimenez S. A., Kaji A. Effects of viral transformation on synthesis and secretion of collagen and fibronectin-like molecules by embryonic chick chondrocytes in culture. J. Biol. Chem. 1981; 256: 9111–9117
   PubMed Web of Science ®Google Scholar
• Sandmeyer S., Gallis B., Bornstein P. Coordinate transcriptional regulation of type I procollagen genes by Rous sarcoma virus. J. Biol. Chem. 1981; 256: 5022–5028
   PubMed Web of Science ®Google Scholar
• Taylor J. P., Cupp C., Diaz A., Chowdhury M., Khalili K., Jimenez S. A., Amini S. Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc. Natl. Acad. Sci. USA 1992; 89: 9617–9621
   PubMed Web of Science ®Google Scholar
• Kekow J., Wachsman W., McCutchan A. A., Cronin M., Carson D. A., Lotz M. Transforming growth factor-β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Nail. Acad. Sci. USA 1990; 87: 8321–8325
   PubMed Web of Science ®Google Scholar
• Cupp C., Taylor J. P., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor-β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 1993; 8: 2231–2236
   PubMed Web of Science ®Google Scholar
• Lotz M., Clark-Lewis I., Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGFβ expression in human articular chondrocytes. J. Cell Biol. 1994; 124: 365–371
   PubMed Web of Science ®Google Scholar
• Jimenez S. A., Varga J., Olsen A., Li L., Diaz A., Hcrhal J., Koch J. Functional analysis of human aid) procollagen gene promoter. Differential activity in collagen-producing and-nonproducing cells and response to transforming growth factor-β1. J. Biol. Chem. 1994; 269: 12684–12691
   PubMedGoogle Scholar
• Kamine J., Subramanian T., Chinnadurai G. Spl-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 1991; 88: 8510–8514
   PubMedGoogle Scholar
• Weeks B. S., Klotman M. E., Dhawan S., Kibbey M., Rappaport J., Kleinman H. K., Yamada K. M., Klotman P. E. HIV-1 infection of human T lymphocytes results in enhanced α5bl integrin expression. J. Cell Biol. 1991; 114: 847–853
   Google Scholar
• Frankel A. D., Pabo C. O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988; 55: 1189–1193
   PubMed Web of Science ®Google Scholar
• Uchijima M., Sato H., Fujii M., Seiki M. Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metallopro-teinases-1, TIMP-1). J. Biol. Chem. 1994; 269: 14946–14950
   PubMed Web of Science ®Google Scholar
• Bounaguro L., Barillari G., Chang H. K., Bohan C. A., Kao V., Morgan R., Gallo R. C., Ensoli B. Effects of human immunodeficiency virus type I Tat protein on the expression of inflammatory cytokines. J. Virol. 1992; 66: 7159–7167
   PubMedGoogle Scholar
• Pun K. K., Aggarwal B. B. Human immunodeficiency virus type I Tat gene upregulates interleukin-4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 1992; 52: 3787–3790
   Google Scholar
• Jang K. L., Collins M. K., Latchman D. S. The human immunodeficiency virus Tat protein increases the transcription of human Alu repeated sequences by increasing the activity of the cellular transcription factor TFIIIC. J. Acquir. Immune Deβc. Syndr. 1992; 5: 1142–1147
   PubMed Web of Science ®Google Scholar
• Fujii M., Niki T., Mori T., Matsuda T., Matsui M., Nomura N., Seiki M. HTLV-1 tax induces expression of various immediate early serum responsive genes. Oncogene 1991; 6: 1023–1029
   PubMed Web of Science ®Google Scholar
• Wano Y., Feinberg M., Hosking J. B., Bogerd H., Greene W. C. Stable expression of the tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth. Proc. Natl. Acad. Sci. USA 1988; 85: 9733–9737
   PubMed Web of Science ®Google Scholar
• Ballard D. W., Böhnlein E., Lowenthal J. W., Wano Y., Franza B. R., Greene W. C. HTLV-I tax induces cellular proteins that activate the kB element in the IL-2 receptor a gene. Science 1988; 241: 1652–1655
   PubMed Web of Science ®Google Scholar
• Leung K., Nabel J. J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kB-like factor. Nature 1988; 333: 776–778
   PubMed Web of Science ®Google Scholar
• Miyatake S., Seiki M., Yoshida M., Arai K.-I. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophagc colony-stimulating factor gene through a common DNA element. Mot. Cell Biol. 1988; 8: 5581–5587
   Google Scholar
• Albrecht H., Shakhov A. N., Jongeneel C. V. Transactivation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I tax-I protein. J. Virol. 1992; 66: 6191–6193
   PubMed Web of Science ®Google Scholar
• Lilienbaum A., Paulin D. Activation of the human vimentin gene by the tax human T-cell leukemia virus I. J. Biol. Chem. 1993; 268: 2180–2188
   PubMed Web of Science ®Google Scholar
• Siekevitz M., Josephs S. F., Dukoich M., Peffer N., Wong-Staal F., Greene W. C. Activation of the HIV-1 LTR by T-cell mitogens and the transactivalor protein of HTLV-1. Science 1987; 238: 1575–1578
   PubMed Web of Science ®Google Scholar
• Kim S.-J., Kehrl J. H., Burton J., Tendler C. L., Jeang K.-T, Danielpour D., Thevenin C., Kim K. Y., Kim M. Y., Spom M. B., Roberts A. B. Transactivation of the transforming growth factor-β1 (TGF-β1) gene by human T lymphotropic virus type I tax: A potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med. 1990; 172: 121–129
   PubMed Web of Science ®Google Scholar
• Kim S.-J., Winokur T. S., Lee H.-D., Danielpour D., Kim K. Y., Geiser A. G., Chen L.-S., Sporn M. B., Roberts A. B., Jay G. Overexpression of transforming growth factor-β in transgenic mice carrying the human T-cell lymphotropic virus type 1. Mol. Cell Biol. 1991; 11: 5222–5228
   PubMedGoogle Scholar
• Itescu S., Brancato L. J., Winchester R. A Sicca syndrome in HIV infection: Association with HLA-DR5 and CDS lymphocytosis. Lancet 1989; i: 466–468
   Google Scholar
• Green J. E., Hinrichs S. H., Vogel J., Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72–76
   PubMed Web of Science ®Google Scholar
• Mariette X., Agbalika F., Daniel M. T., Bisson M., Lagrange P., Brouet J. C., Morinet F. Detection of human T-lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum. 1993; 10: 1423–1428
   Google Scholar
• Sumida T., Yonaha F., Maeda T., Kita Y., Iwamoto I., Koike T., Yoshida S. Expression of sequences homologous to HTLV-1 tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum. 1994; 37: 545–550
   PubMed Web of Science ®Google Scholar
• Rappaport J., Koop J. B., Klatman P. E. Host virus interactions and the molecular regulation of HIV-1 role in the pathogenesis of HIV-associated nephropathy. Kidney Int. 1994; 46: 16–27
   Google Scholar
• Dickie P., Felser J., Eckhaus M., Bryant J., Silver J., Marines N., Notkins A. J. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991; 185: 109–119
   PubMed Web of Science ®Google Scholar
• Kopp J. B., Klotman M. E., Adler S. H., Bruggeman L. A., Dickie P., Marines N. J., Eckhaus M., Bryant J. L., Notkins A. L., Klotman P. E. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc. Natl. Acad. Sci. USA 1992; 89: 1577–1581
   PubMed Web of Science ®Google Scholar